Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
Clinical trial NCT01126099 · COMPLETED
Trial details
- NCT number
- NCT01126099
- Sponsor
- Seattle Institute for Biomedical and Clinical Research
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2014-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.